World · India Bureau
UK firm launches DNA testing kits in India targeting wellness market
A British health science company has partnered with a local distributor to introduce genetic and epigenetic testing services across India, with projected revenues of £3-5 million. The kits, priced between ₹25,000 and ₹85,000, aim to tap growing demand for personalised health insights among Indian consumers.
LSN India ·
Bio-Synergy, a UK-based health science firm, has entered into a partnership with Kynora Life Sciences to distribute its DNA and epigenetics testing kits in the Indian market. The move marks the company's expansion into South Asia's growing wellness sector, where consumer interest in personalised healthcare solutions has surged in recent years.
The testing kits will be offered at price points ranging from ₹25,000 to ₹85,000, positioning them within India's premium wellness segment. The services are designed to provide customers with insights into their genetic profiles and epigenetic markers, enabling them to make informed decisions about nutrition, fitness, and overall health management.
Bio-Synergy has set revenue targets of £3-5 million from the Indian market, reflecting confidence in the commercial potential of personalised genomics in the region. The partnership with Kynora Life Sciences is intended to provide local market expertise and distribution infrastructure necessary to reach consumers across major urban centres.
The launch comes as Indian consumers increasingly seek personalised health solutions beyond traditional medical consultations. Advances in genetic testing technology and rising health consciousness have created a receptive market for such offerings, particularly among middle and upper-income households.